Metabolic
Efinopegdutide
Also called MK-6024, HM12525A
per administration
It has been used in people, but no trial has settled how much or how often.
Work out your draw
These numbers are a starting point — change any of them.
- Concentration
- 3.33mg/mL
- Volume per draw
- 1.5mL
- Units to dial
- 150
- Doses per cartridge
- 2
This is 150 units, past the 60-unit dial. Splitting it across administrations, or using less water to raise the concentration, brings it back into range.
Dial range varies by pen; 1–60 units is the common configuration.
Vial label
Copy this into your label printer.
Published research contexts for Efinopegdutide describe 5–10 mg per administration. Descriptive only, not a recommendation.
Multi-day, consistent with once-weekly administration; human figures are not well characterized.
A GLP-1 and glucagon dual receptor agonist studied for weight and liver-fat reduction in phase 2 research. No confirmed dose-ranging publication fixes a subcutaneous schedule for general use, so no schedule table is shown.
Modelled level — once a week
1× is the peak after a single dose.
- Steady-state peak
- 1.57× single dose
- Time to steady state
- 25.0days
- Administrations
- 1/ week
Read off the modelled curve, not an even-interval formula
About five half-lives
Where these numbers come from
- Efinopegdutide (MK-6024 / HM12525A) phase 2 programWeekly subcutaneous dosing studied for hepatic fat reduction; the amounts are early-phase, not schedule-establishing.